This page includes the latest FDA filings for Morphosys Us Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
Device Company | Device | Date |
|---|---|---|
| MorphoSys US Inc., Boehringer Ingelheim Pharma GmbH & Co KG, BioReliance Ltd, Pacific BioLabs, Millmount Healthcare Limited (known as PCI Pharma Services), Integrated Commercialization Solutions, LLC, Morphosys US Inc | Prescription Medication | 2023-06-25 |
| MorphoSys US Inc., Boehringer Ingelheim Pharma GmbH & Co KG, BioReliance Ltd, Pacific BioLabs, Millmount Healthcare Limited (known as PCI Pharma Services), Integrated Commercialization Solutions, LLC, Morphosys US Inc | Prescription Medication | 2022-12-03 |
| MorphoSys US Inc., Boehringer Ingelheim Pharma GmbH & Co KG, BioReliance Ltd, Pacific BioLabs, Millmount Healthcare Limited (known as PCI Pharma Services), Integrated Commercialization Solutions, LLC, Morphosys US Inc | Prescription Medication | 2021-06-08 |
| MorphoSys US Inc., Boehringer Ingelheim Pharma GmbH & Co KG, BioReliance Ltd, Pacific BioLabs, Millmount Healthcare Limited (known as PCI Pharma Services), Integrated Commercialization Solutions, LLC, Morphosys US Inc | Prescription Medication | 2020-09-10 |
MORPHOSYS US INC | 2020-08-05 00:37:31 | |
| MorphoSys US Inc. | MONJUVI | 2020-08-05 |
| MorphoSys US Inc., Boehringer Ingelheim Pharma GmbH & Co KG, BioReliance Ltd, Pacific BioLabs, Millmount Healthcare Limited (known as PCI Pharma Services), Integrated Commercialization Solutions, LLC, Morphosys US Inc | Prescription Medication | 2020-08-05 |
| NCAGE Code | 8H8E3 | MORPHOSYS US INC |
| CAGE Code | 8H8E3 | MORPHOSYS US INC |
| S.A.M. Registration | 8H8E3 [100556743] | MORPHOSYS US INC |